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Case report Hepatic breast cancer dissemination after an 
iatrogenic hepatic laceration during talc 
pleurodesis: a case report
Joaquim Bosch-Barrera* and Jaime Espinós
Abstract
Background: Talc pleurodesis is an effective treatment for malignant pleural effusion. We present a case of an 
asymptomatic hepatic laceration that occurred during pleurodesis in a breast cancer patient and led to hepatic tumor 
dissemination.
Discussion: Pleurodesis is a relatively safe procedure, although previous studies have described malignant invasion of 
scar tissue.
Conclusion: To our knowledge, this is the first case report of tumor spread due to a liver puncture during talc 
pleurodesis in a breast cancer patient.
Background
Malignant pleural effusion (MPE) is common in patients
with advanced cancer [1]. The primary neoplasms that
most frequently cause MPE are lung cancer in men and
breast cancer in women. Talc pleurodesis is a widely used
technique for the treatment of MPE [2]. We present a
case report of an asymptomatic complication during talc
pleurodesis that caused a hepatic dissemination of a
breast tumor that was eventually fatal.
Case presentation
A 59-year-old woman was admitted to her reference hos-
pital for dyspnea. Chest radiography showed a severe
right pleural effusion. Her medical history included
breast cancer (pT2pN1M0) diagnosed when she was 52,
which was treated with surgery, adjuvant chemotherapy,
adjuvant radiotherapy and hormonotherapy (3 years of
tamoxifen and 2 years of letrozole). The patient did not
have other diseases or congenital malformations and had
not required previous abdominal or thoracic surgeries.
The last normal follow-up was 2 months prior to her
admission for the dyspnea. A thoracic tube was inserted,
and 1,000 cc of pleural fluid was drained. After cytology
revealed the presence of malignant breast cells, right-
sided talc pleurodesis was performed. The patient had a
good postoperative evolution, without fever or pain, and
was discharged four days after the talc pleurodesis.
The patient came to our center for oncological treat-
ment. A staging CT scan showed a heterogeneous hepatic
lesion (9 × 6.5 cm) with air inside (Fig. 1). In addition,
bone and pleural affectation from the patient's metastatic
breast cancer were observed. The patient was asymptom-
atic, without fever, abdominal pain or abnormal labora-
tory tests. A hepatic abscess was ruled out because of her
clinical history, and a hepatic laceration made during the
talc-injection procedure was suspected. Hormonal treat-
ment (exemestane) was started. A new CT scan was per-
formed one month later. A diffuse malignant hepatic
infiltration was observed (Fig. 2) without any tumor pro-
gr e s s i o n  a t  d is t a l  s i t e s.  La bo r a t o ry  a n a l ys is  yi e l d ed  t h e
following values: bilirubin 1.66 mg/dL; GOT 146 UI/L;
GPT 112 UI/L; LDH 2,934 UI/L; GGT 1,405 UI/L; and
alkaline phosphatase 1,383 UI/L. An initial cycle of 50
mg/m2 doxorubicin hydrochloride and 500 mg/m2 cyclo-
phosphamide was administered. The patient died four
weeks later as a result of hepatic failure.
Discussion
Talc pleurodesis is recognized as the procedure of choice
for the treatment of MPE [2], and a meta-analysis has
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confirmed the superiority of talc as a sclerosing agent [3].
However, some studies have generated concerns about
the safety of the procedure [4-6]. The adverse effects
reported include mild fever, chest pain and, more rarely,
acute respiratory distress syndrome (ARDS), empyema,
wound infection and malignant invasion of scar tissue
[7,8]. To our knowledge, this is the first case reporting a
hepatic laceration due to talc pleurodesis followed by
hepatic tumor spread.
A CT scan performed before of the pleurodesis did not
show any hepatic lesion and liver tests were normal in
that moment. In this patient, the initial diagnostic suspi-
cion of a hepatic abscess was supported by the CT image,
but normal blood tests and the absence of clinical symp-
toms ruled it out after 24 hours of observation. Conse-
quently hormonal treatment was preferred over
chemotherapy to avoid immunosuppression, which could
have complicated the treatment of a hepatic infection.
We presumed that the advanced malignant hepatic pro-
gression was secondary to breast tumor cell dissemina-
tion due to the introduction of malignant pleural effusate
into the liver. This condition could also have been the
result of systemic dissemination, but no other locations
exhibited disease progression and the hepatic dissemina-
tion was surprisingly rapid. Moreover, malignant invasion
of scar tissue after talc pleurodesis has been described
previously [5]. Another possible explanation for the pres-
ence of tumor cells in the abdomen could be a direct
communication between the abdominal cavity and tho-
rax due to a diaphragmatic defect, but our patient did not
have previous diaphragmatic defects. In 1998, Kirschner
described the porous diaphragm syndrome (PDS) [9].
The PDS is connected to the pass from the peritoneal
cavity to the pleural space. We consider that the absence
of ascites during the course of the disease and the pres-
ence of intrahepatic metastases without implants in the
liver capsule excludes this possibility in our case.
Conclusions
To our knowledge, this is the first case report of tumor
spread due to a liver puncture during talc pleurodesis in a
breast cancer patient. This complication must be taken
into account when pleurodesis is performed.
Consent
Written informed consent was obtained from the
patient's relatives for publication of this case report and
any accompanying images. A copy of the written consent
is available for review by the Editor-in-Chief of this jour-
nal.
Abbreviations
MPE: malignant pleural effusion; CT: Computed Tomography; GOT: glutamic-
oxaloacetic transaminase; GPT: Glutamic-pyruvic transaminase; LDH: Lactate
dehydrogenase; GGT: Gamma glutamyl transpeptidase.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
JB-B developed the concept and wrote the draft. JB-B and JE contributed to
the final manuscript version and have given final approval of this version.
Author Details
Department of Oncology, Clínica Universidad de Navarra, Universidad de 
Navarra, Calle Pío XII 36, 31008, Pamplona, Spain
References
1. Chen H, Brahmer J: Management of malignant pleural effusion.  Curr 
Oncol Rep 2008, 10:287-293.
2. Lombardi G, Zustovich F, Nicoletto MO, Donach M, Artioli G, Pastorelli D: 
Diagnosis and Treatment of Malignant Pleural Effusion: A Systematic 
Literature Review and New Approaches.  Am J Clin Oncol 2009 in press.
Received: 2 February 2010 Accepted: 6 May 2010 
Published: 6 May 2010
This article is available from: http://www.intarchmed.com/content/3/1/6 © 2010 Bosch-Barrera and Espinós; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. International Archives of Medicine 2010, 3:6
Figure 1 A heterogeneous hepatic lesion with air and dense con-
tent (talc) was observed after talc injection into the liver.No he-
patic metastasis was observed at this time.
Figure 2 A dense region corresponding to the site of talc injec-
tion was observed one month later. Multiple liver metastases 
were also observed.Bosch-Barrera and Espinós International Archives of Medicine 2010, 3:6
http://www.intarchmed.com/content/3/1/6
Page 3 of 3
3. Shaw P, Agarwal R: Pleurodesis for malignant pleural effusions.  
Cochrane Database Syst Rev 2004:CD002916.
4. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, 
Loddenkemper R, Herth FJ, Gasparini S, Marquette CH, Becke B, 
Froudarakis ME, Driesen P, Bolliger CT, Tschopp JM: Safety of pleurodesis 
with talc poudrage in malignant pleural effusion: a prospective cohort 
study.  Lancet 2007, 369:1535-1539.
5. Kolschmann S, Ballin A, Gillissen A: Clinical efficacy and safety of 
thoracoscopic talc pleurodesis in malignant pleural effusions.  Chest 
2005, 128:1431-1435.
6. Stefani A, Natali P, Casali C, Morandi U: Talc poudrage versus talc slurry in 
the treatment of malignant pleural effusion. A prospective 
comparative study.  Eur J Cardiothorac Surg 2006, 30:827-832.
7. Laisaar T, Palmiste V, Vooder T, Umbleja T: Life expectancy of patients 
with malignant pleural effusion treated with video-assisted 
thoracoscopic talc pleurodesis.  Interact Cardiovasc Thorac Surg 2006, 
5:307-310.
8. Lee YC, Baumann MH, Maskell NA, Waterer GW, Eaton TE, Davies RJ, 
Heffner JE, Light RW: Pleurodesis practice for malignant pleural 
effusions in five English-speaking countries: survey of pulmonologists.  
Chest 2003, 124:2229-2238.
9. Kirschner PA: Porous diaphragm syndromes.  Chest Surg Clin N Am 1998, 
8:449-72.
doi: 10.1186/1755-7682-3-6
Cite this article as: Bosch-Barrera and Espinós, Hepatic breast cancer dis-
semination after an iatrogenic hepatic laceration during talc pleurodesis: a 
case report International Archives of Medicine 2010, 3:6